U.S. Stocks Open Lower on Thursday; Wolfspeed Surges 12% on $1.5 Billion Pentagon Financing Deal; Argenx Shares Plunge 11% After Autoimmune-Disease Trial Halt

Tiger Newspress10-08 21:30

U.S. stocks moved lower on Thursday as investors faced more pressure from rising Treasury yields and elevated oil prices.

The Dow Jones Industrial Average fell 181 points, or 0.4%. The S&P 500 dipped 0.4%, and the Nasdaq Composite was down 0.5%.

The benchmark 10-year Treasury note yield rose more than 5 basis points to 5.331%, around levels not seen since 2002. The 30-year Treasury bond yield also traded near 24-year highs at 5.702% after rising more than 4 basis points. Those moves came after Federal Reserve Governor Christopher Waller said more hikes may be needed to curb inflation.

Argenx fell 11% after the biotech company stopped a late-stage clinical trial of its Vyvgart drug due to lack of efficacy for the treatment of autoimmune condition Sjogren’s disease.

Wolfspeed surged 16% after it landed a financing deal with the Pentagon. The Defense Department will give the company $1.5 billion in long-term 30-year financing, contingent on it producing silicon carbide materials and other power devices in the U.S.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment